| Li, Liangping |
NCT05486104: Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis |
|
|
| Recruiting | 2 | 108 | RoW | Hemay005 tablets, Hemay005 45 mg BID group, Hemay005 placebo tablets, Hemay005 placebo BID group | Ganzhou Hemay Pharmaceutical Co., Ltd | Moderate to Severe Ulcerative Colitis | 06/24 | 09/24 | | |
NCT05632861: HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR) |
|
|
| Recruiting | 2 | 76 | RoW | HuHuangLianzonggan capsule, Experimental group, HuHuangLianzonggan capsule placebo, Placebo group | Tasly Pharmaceutical Group Co., Ltd | NASH | 12/24 | 12/24 | | |
| Li, Yongqiang |
TQB2102-II-04, NCT06767800: A Clinical Trial Evaluating TQB2102 for Injection in Combination With Benmelstobart/Penpulimab With or Without Capecitabine in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma |
|
|
| Not yet recruiting | 2 | 168 | RoW | TQB2102 for injection+Benmelstobart, TQB2102 for injection+Benmelstobart+Capecitabine | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Gastroesophageal Adenocarcinoma | 09/26 | 09/27 | | |
| Recruiting | 1/2 | 364 | RoW | SHR-A1811 combined with Pyrotinib., SHR-A1811 combined with other antitumor therapies | Jiangsu HengRui Medicine Co., Ltd. | HER2-expressing Advanced Solid Tumors | 11/26 | 12/26 | | |
NCT06010901: A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. |
|
|
| Recruiting | 1 | 75 | RoW | TQB2618 injection, Penpulimab injection, Anlotinib hydrochloride capsules | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Colorectal Cancer | 03/25 | 07/25 | | |
| Xu, Jin-Fu |
NCT04511897: Efficacy and Safety of An'Ningpai Expectorant in Non-CF Bronchiectasis |
|
|
| Not yet recruiting | 4 | 200 | NA | An'ningpai, Expectorant | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis Adult | 12/22 | 06/23 | | |
NCT04509661: Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation |
|
|
| Not yet recruiting | 4 | 200 | NA | LABA/LAMA or Placebo inhalation, Inhaled dual Bronchodilator | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis Adult | 06/24 | 06/24 | | |
ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis |
|
|
| Recruiting | 4 | 364 | RoW | Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis Adult, Pseudomonas Aeruginosa Infection | 10/25 | 12/25 | | |
NCT03643185: Cytokine Profile of Allergic Bronchopulmonary Aspergillosis |
|
|
| Recruiting | N/A | 100 | RoW | | Shanghai Pulmonary Hospital, Shanghai, China | ABPA | 05/21 | 05/21 | | |
NCT04490447: Identification of Microbiome and Metabolome of Bronchiectasis in Chinese Population. |
|
|
| Recruiting | N/A | 160 | RoW | | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis | 06/21 | 09/21 | | |
NCT05293314: Assessment of an Exhaled Breath Test to Detect Bronchiectasis |
|
|
| Recruiting | N/A | 188 | RoW | an exhaled breath test | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis | 06/23 | 12/23 | | |
NCT06393257: Airway Clearance Technique of Oscillation and Lung Expansion in Bronchiectasis |
|
|
| Recruiting | N/A | 96 | RoW | Oscillation and Lung Expansion, Postural drainage, Anti-infective therapy, Mucolytic | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis Adult | 09/25 | 05/26 | | |
NCT06760273: Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II) |
|
|
| Enrolling by invitation | N/A | 364 | RoW | No Intervention: Observational Cohort | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis Adult | 12/27 | 12/27 | | |
NCT03643653: The Establishment of China Bronchiectasis Registry and Research Collaboration |
|
|
| Recruiting | N/A | 10000 | RoW | | Shanghai Pulmonary Hospital, Shanghai, China, Ruijin Hospital, Shanghai Zhongshan Hospital | Bronchiectasis | 12/25 | 12/25 | | |
NCT04554875: Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules |
|
|
| Recruiting | N/A | 1000 | RoW | A scoring system | Shanghai Pulmonary Hospital, Shanghai, China | Cryptococcosis, Lung Adenocarcinoma | 06/21 | 07/21 | | |
NCT05604495: Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis |
|
|
| Recruiting | N/A | 1000 | RoW | Sweat Test | Shanghai Pulmonary Hospital, Shanghai, China | Cystic Fibrosis, Pulmonary | 12/24 | 12/24 | | |
| Jiang, Fan |
NCT04048785: Behavioral Sleep Intervention and Infant Sleep and Social-emotional Development |
|
|
| Recruiting | N/A | 100 | RoW | Behavioral sleep intervention | Shanghai Jiao Tong University School of Medicine | Infant Sleep Problem | 09/21 | 12/21 | | |
UDFF, NCT05802199: Quantitative Detection Efficiency of for Nonalcoholic Fatty Liver Disease |
|
|
| Recruiting | N/A | 300 | Europe, RoW | Hepatic fat fraction and hepatic fibrosis | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Zhongda Hospital, Zhejiang University, Lishui Country People's Hospital, Shandong Public Health Clinical Center, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, First Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital with Nanjing Medical University, The Second Hospital of Anhui Medical University, The People's Hospital of Bozhou, The First Affiliated Hospital of Xiamen University, The First Hospital of Jilin University, Kliniken Hirslanden Beau Site, Salem und Permancence, Third People's Hospital of Zhenjiang, Jiangsu University | Non-alcoholic Fatty Liver Disease | 12/23 | 12/23 | | |
NCT06025669: Effects of Nap Restriction on Preschoolers' Empathy, Prosocial Behaviors and Executive Function |
|
|
| Completed | N/A | 25 | RoW | Nap restriction | Shanghai Jiao Tong University School of Medicine | Sleep Restriction | 12/23 | 12/23 | | |
| Recruiting | N/A | 80 | RoW | Metacognitive Therapy, General mental health promotion | Northeast Normal University | Obsessive-Compulsive Disorder | 09/24 | 11/24 | | |
FLAVOUR II, NCT04397211: Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease |
|
|
| Active, not recruiting | N/A | 1872 | RoW | Angiography-derived FFR, IVUS | Second Affiliated Hospital, School of Medicine, Zhejiang University, Seoul National University Hospital, Affiliated Hangzhou First People's Hospital, Wuhan University, Peking University Third Hospital, The Affiliated Hospital of Hangzhou Normal University, RenJi Hospital, Second Hospital of Shanxi Medical University, First Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital of Wenzhou Medical University, Changxing People's Hospital, The Affiliated Hospital of Medical College, Ningbo University, Jinhua Central Hospital, Shandong University of Traditional Chinese Medicine, Dongyang People's Hospital, The First Affiliated Hospital of Nanchang University, Jining First People's Hospital, Second Affiliated Hospital of Shantou University Medical College, Ulsan University Hospital, Huizhou Municipal Central Hospital, Zhejiang Greentown Cardiovascular Hospital, The Fourth People's Hospital of Jinan, First Affiliated Hospital of Kunming Medical University | Coronary Artery Disease | 09/24 | 09/28 | | |
MIND, NCT04916652: A First-ever Research Collaboration to Characterize MRI Measured Neural Flexibility Development in Chinese Toddlers |
|
|
| Not yet recruiting | N/A | 60 | RoW | MRI | Société des Produits Nestlé (SPN), SAS Institute, Veeva Systems | Growth & Development, Brain | 02/25 | 03/25 | | |
NCT04037761: Shanghai Children's Health, Education and Lifestyle Evaluation, Preschool (the SCHEDULE-P Study) |
|
|
| Recruiting | N/A | 20899 | RoW | | Sijia Gu | Child Development | 12/30 | 12/30 | | |
| Sun, Zhiqi |
OPTIMA-6, NCT05410925: Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction |
|
|
| Recruiting | 4 | 2260 | RoW | Recombinant staphylokinase, Placebo | The First Affiliated Hospital with Nanjing Medical University | ST Elevation Myocardial Infarction | 12/26 | 12/27 | | |
NCT06365502: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) |
|
|
| Recruiting | N/A | 1860 | RoW | Drug-coated balloon, Guideline-directed medical treatment | Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd | Acute Coronary Syndrome (ACS) | 12/27 | 12/30 | | |
NCT05862103: Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort |
|
|
| Recruiting | N/A | 15000 | RoW | Treatment Strategies | Yu Bo | Acute Myocardial Infarction, Adverse Event | 08/25 | 12/26 | | |
| Shi, Junping |
NCT05193916: A Phase II Clinical Trial of Chiglitazar for NASH |
|
|
| Completed | 2 | 104 | RoW | chiglitazar sodium tablets, Bilessglu®, CS-038, Carfloglitazar, Placebo, simulant of chiglitazar | Chipscreen Biosciences, Ltd. | NASH | 01/24 | 01/24 | | |
NCT05462353: Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH |
|
|
| Active, not recruiting | 2 | 183 | RoW | 2mg of ASC41, 4mg of ASC41 (2 tablets of 2 mg ASC41), Placebo | Gannex Pharma Co., Ltd. | Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis | 05/25 | 06/25 | | |
NCT05632861: HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR) |
|
|
| Recruiting | 2 | 76 | RoW | HuHuangLianzonggan capsule, Experimental group, HuHuangLianzonggan capsule placebo, Placebo group | Tasly Pharmaceutical Group Co., Ltd | NASH | 12/24 | 12/24 | | |
NCT06795646: Clinical Classification of MAFLD Based Liver Biopsy |
|
|
| Not yet recruiting | N/A | 2000 | RoW | | Beijing Friendship Hospital, Fudan University, Tianjin Second People's Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, The Affiliated Hospital of Hangzhou Normal University, Ruijin Hospital | Metabolic Dysfunction Associated Steatotic Liver Disease, Metabolic Dysfunction-associated Steatohepatitis (MASH) | 12/28 | 12/38 | | |
| Hu, Peng |
| Active, not recruiting | 4 | 640 | RoW | Tenofovir Amibufenamide（TMF）, HS-10234 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Hepatitis B, Chronic | 06/24 | 09/29 | | |
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection |
|
|
| Completed | 2 | 250 | RoW | GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table | Sunshine Lake Pharma Co., Ltd. | Chronic HBV Infection | 06/22 | 09/23 | | |
| Recruiting | 2 | 116 | RoW | Placebo, TQA3334 Tablet, Nucleoside (acid) analogs (NAs) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Chronic Hepatitis B | 12/25 | 06/26 | | |
NCT06452693: A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B |
|
|
| Not yet recruiting | 1/2 | 162 | RoW | TQA3038 injection/placebo, Nucleotide drugs Control group | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Hepatitis B, Chronic | 09/26 | 09/26 | | |
NCT05888545: Clinical Study on a Novel Anti-adhesion Barrier Film |
|
|
| Recruiting | N/A | 1176 | RoW | anti-adhesion diaphragm | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Intrauterine Adhesion | 12/24 | 12/24 | | |
NCT05965843: Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases |
|
|
| Not yet recruiting | N/A | 480 | NA | underling disease | The Second Affiliated Hospital of Chongqing Medical University | Chronic Liver Disease, Malignant Tumor, Autoimmune Diseases, Healthy | 12/23 | 12/24 | | |
NCT05755776: The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment |
|
|
| Recruiting | N/A | 204 | RoW | TMF, Heng Mu | The Second Affiliated Hospital of Chongqing Medical University, Jiangsu Hansoh Pharmaceutical Co., Ltd. | Chronic Hepatitis B | 12/24 | 12/24 | | |
| Shi, Jun-Ping |
| Recruiting | 4 | 120 | RoW | Lifestyle intervention, Placebo, Berberine | Fudan University, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, The Affiliated Hospital of Hangzhou Normal University, Tianjin Third Central Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Xinjiang Medical University | Non-alcoholic Steatohepatitis | 12/23 | 07/24 | | |
| Wang, Ziping |
SELECT-2, NCT04401059: Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study |
|
|
| Recruiting | 4 | 744 | RoW | Elemene plus first or third generation EGFR-TKIs, H10960114, H20010338, First or third generation EGFR-TKIs, Gefitinib(Iressa,YiRuiKe), Erlotinib(Tarceva), Icotinib(Kaimeina), Osimertinib(Tagrisso), Almonertinib, Furmonertinib, etc. | Tian Xie, LinkDoc Technology (Beijing) Co. Ltd. | Carcinoma, Non-Small-Cell Lung Cancer, Adenocarcinoma | 09/25 | 03/26 | | |
YH001, NCT05212922: A Study to Evaluate in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC |
|
|
| Withdrawn | 2 | 80 | Europe, RoW | YH001 + Toripalimab | Eucure (Beijing) Biopharma Co., Ltd | HCC, NSCLC Stage IIIB, NSCLC Stage IV | 12/24 | 03/25 | | |
| Recruiting | 1/2 | 280 | RoW | SAF-189s, foritinib succinate | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Advanced Cancer, Advanced Solid Tumor, Lung Cancer, Nonsmall Cell | 12/22 | 03/26 | | |
GLORY, NCT04270591: Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer |
|
|
| Recruiting | 1/2 | 183 | Japan, US, RoW | Glumetinib, SCC244 | Haihe Biopharma Co., Ltd. | C-Met Exon 14 Mutation | 10/23 | 12/23 | | |
NCT04993391: AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer |
|
|
| Recruiting | 1/2 | 156 | RoW | JS111(AP-L1898 Capsules) | Suzhou Junjing BioSciences Co., Ltd. | Lung Cancer | 06/24 | 08/24 | | |
NCT04956926: Clinical Study of JS201 in Patients With Advanced Malignant Tumors |
|
|
| Recruiting | 1 | 244 | RoW | JS201 | Shanghai Junshi Bioscience Co., Ltd. | Patients With Advanced Malignant Tumors | 07/23 | 07/23 | | |
NCT05508334: A Study to Assess the Safety and Tolerability of RC88 for Patients with Advanced Solid Tumours |
|
|
| Active, not recruiting | 1 | 81 | RoW | RC88, The injectable RC88 | RemeGen Co., Ltd. | Advanced Solid Tumours | 06/25 | 12/25 | | |
NCT02929290: Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCLC |
|
|
| Recruiting | 1 | 80 | RoW | BPI-9016M, No other name so far | Betta Pharmaceuticals Co., Ltd. | Non-small Cell Lung Cancer | 11/24 | 11/24 | | |
SELECT-1, NCT04397432: Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Retrospective Study |
|
|
| Active, not recruiting | N/A | 878 | RoW | | Tian Xie, LinkDoc Technology (Beijing) Co. Ltd. | Carcinoma, Non-Small-Cell Lung | 04/23 | 03/26 | | |
| Chen, Gongying |
NCT03236636: The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects |
|
|
| Recruiting | 3 | 312 | RoW | Icaritin, SNG-162, HUACHANSU PIAN, HUACHANSU PIAN（999） | Beijing Shenogen Biomedical Co., Ltd, Chinese Academy of Medical Sciences, NanJing PLA 81 Hospital, Peking University Cancer Hospital & Institute, Beijing Hospital, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Jinan Central Hospital, Linyi Tumour Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China, Nanfang Hospital of Southern Medical University, First People's Hospital of Foshan, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Hebei Medical University Fourth Hospital, The First Hospital of Jilin University, Haikou People's Hospital, Fudan University, West China Hospital, Chongqing Traditional Chinese Medicine Hospital, Chifeng Municipal Hospital, The Affiliated Hospital of Hangzhou Normal University, The First Affiliated Hospital of Zhengzhou University, Guilin Medical University, China, The Third Xiangya Hospital of Central South University, Yunnan Provincial Hospital of Traditional Chinese Medicine, The Sixth People's Hospital of Shenyang | Advanced HBV-Related Hepatocellular Carcinoma (HCC) | 12/22 | 12/22 | | |
| Zhang, Qiuling |
NCT05426018: The Efficacy and Safety of Different Doses of SY-009 in Patients With Type 2 Diabetes Mellitus |
|
|
| Not yet recruiting | 2 | 200 | RoW | SY-009 capsules | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | Type 2 Diabetes | 06/23 | 10/23 | | |
| Yang, Deye |
NCT04539860: Comparison of Blood Pressure Measurements Between Transdermal Optical Imaging and Standard of Care |
|
|
| Recruiting | N/A | 15000 | Canada, RoW | Transdermal Optical Imaging | University of Toronto, Nuralogix Corporation, The Affiliated Hospital of Hangzhou Normal University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Blood Pressure | 08/21 | 08/21 | | |
| Shou, Lan |
NCT04682795: Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM |
|
|
| Recruiting | N/A | 200 | RoW | Needle-free injector, Insulin pen | Second Affiliated Hospital, School of Medicine, Zhejiang University | T2DM (Type 2 Diabetes Mellitus), Needle-free Injector, Time in Range | 12/22 | 12/22 | | |
| Lu, Xiaodong |
| Active, not recruiting | 4 | 800 | RoW | Sodium Oligomannate Capsules (GV-971) | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 01/25 | 06/25 | | |
| Zhao, Baiyun |
NCT05784779: Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD |
|
|
| Recruiting | 1/2 | 180 | RoW | GH509, Placebo | 1Globe Biomedical Co., Ltd. | NASH, NAFLD | 05/24 | 06/24 | | |
| Jie, Zhi-jun |
ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis |
|
|
| Recruiting | 4 | 364 | RoW | Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis Adult, Pseudomonas Aeruginosa Infection | 10/25 | 12/25 | | |
| Hu, Wanying |
FLAVOUR III, NCT06218485: FFR Versus IVUS With Angiography-Derived FFR for Clinical Outcomes in Patients With Coronary Artery Disease |
|
|
| Not yet recruiting | N/A | 1936 | RoW | Intravascular ultrasound-guided stent implantation after angiography-derived FFR-based decision-making, Fractional flow reserve-guided PCI strategy | Second Affiliated Hospital, School of Medicine, Zhejiang University, Seoul National University Hospital, Peking University Third Hospital, RenJi Hospital, Second Affiliated Hospital of Shantou University Medical College, The First Affiliated Hospital of Nanchang University, First Affiliated Hospital of Kunming Medical University, The Fourth People's Hospital of Jinan, Jinhua Central Hospital, The Affiliated Hospital of Hangzhou Normal University, Changxing People's Hospital, First Affiliated Hospital of Wenzhou Medical University, The Affiliated Hospital of Medical College, Ningbo University, Keimyung University Dongsan Medical Center, Inje University Ilsan Paik Hospital, Ulsan University Hospital, Uijeongbu Eulji Medical Center, Kyungpook National University Hospital, Seoul St. Mary's Hospital, Yonsei University Wonju Severance Hospital, Inje University Haeundae Paik Hospital, Bucheon Sejong Hospital, Chonnam National University Hospital, Ningbo Medical Center Lihuili Hospital, Shandong University of Traditional Chinese Medicine | Coronary Artery Disease | 12/27 | 12/29 | | |
| Dong, Peng |
OPTIMA-6, NCT05410925: Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction |
|
|
| Recruiting | 4 | 2260 | RoW | Recombinant staphylokinase, Placebo | The First Affiliated Hospital with Nanjing Medical University | ST Elevation Myocardial Infarction | 12/26 | 12/27 | | |
NCT06502938: A Clinical Trial Evaluating the Pan-vascular Interventional Robotic System for Panvascularization Interventional Surgery |
|
|
| Not yet recruiting | N/A | 159 | RoW | Pan-vascular interventional robotic system, Traditional artificial percutaneous coronary intervention | Shenzhen Institute of Advanced Biomedical Robot Co., Ltd. | Percutaneous Coronary Intervention | 07/25 | 12/25 | | |
| Liu, Xian-sheng |
ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis |
|
|
| Recruiting | 4 | 364 | RoW | Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis Adult, Pseudomonas Aeruginosa Infection | 10/25 | 12/25 | | |
